Reven Hires Crysta Huszai. Crysta Huszai hired as Reven’s Quality Specialist.
Author Archives: Administrator
2018/11/13 Reven News Press
| Featured
MAD Cohort 1 Begins. MAD Cohort 1 begins seven-day dosing period.
2018/10/26 Reven News Press
| Featured
SAD Cohort 5 Completed. SAD Cohort 5B doses subjects; Cohort 5 has finished.
2018/09/21 Reven News Press
| Featured
Reven announced today that Peter Pacult has been promoted to the position of Senior Director of Clinical Operations. Mr. Pacult’s role will focus on leading Reven’s clinical efforts. In addition, Dane Baruzini has been promoted to Senior Director of Commercial … Read More
2018/09/07 Reven News Press
| Featured
Reven’s Phase 1 Clinical Trial Begins. Reven doses their first subjects (Cohort 1A) under open IND successfully kicking off Phase 1 Clinical Trial.